Oneness Biotech Co., Ltd. (TPEX:4743)
64.50
+1.00 (1.57%)
Oct 28, 2025, 1:30 PM CST
Oneness Biotech Market Cap
Oneness Biotech has a market cap or net worth of 30.85 billion as of October 28, 2025. Its market cap has decreased by -53.98% in one year.
Market Cap
30.85B
Enterprise Value
25.92B
Revenue
112.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
64.50
Market Cap Chart
Since June 22, 2009, Oneness Biotech's market cap has increased from 1.24B to 30.85B, an increase of 2,388.24%. That is a compound annual growth rate of 21.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2025 | 30.37B | -27.14% |
| Dec 31, 2024 | 41.68B | -52.65% |
| Dec 29, 2023 | 88.03B | -7.55% |
| Dec 30, 2022 | 95.22B | -13.04% |
| Dec 30, 2021 | 109.49B | 21.98% |
| Dec 31, 2020 | 89.76B | 772.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 255.92B |
| PharmaEssentia | 186.77B |
| Bora Pharmaceuticals Co., LTD. | 78.82B |
| Lotus Pharmaceutical | 75.21B |
| Lumosa Therapeutics | 45.65B |
| Polaris Group | 27.58B |
| Center Laboratories | 25.61B |
| Pegavision | 25.39B |